197 related articles for article (PubMed ID: 11295713)
21. Clinical and echocardiographic outcome in patients receiving carvedilol for treatment of dilated cardiomyopathy.
Saxena A; Anil OM; Juneja R
Indian J Pediatr; 2013 Jul; 80(7):549-54. PubMed ID: 23412984
[TBL] [Abstract][Full Text] [Related]
22. Treatment of dilated cardiomyopathy with carvedilol in children.
Erdoğan I; Ozer S; Karagöz T; Celiker A; Ozkutlu S; Alehan D
Turk J Pediatr; 2009; 51(4):354-60. PubMed ID: 19950843
[TBL] [Abstract][Full Text] [Related]
23. Safety and efficacy of carvedilol therapy for patients with dilated cardiomyopathy secondary to muscular dystrophy.
Rhodes J; Margossian R; Darras BT; Colan SD; Jenkins KJ; Geva T; Powell AJ
Pediatr Cardiol; 2008 Mar; 29(2):343-51. PubMed ID: 17885779
[TBL] [Abstract][Full Text] [Related]
24. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial.
Hori M; Sasayama S; Kitabatake A; Toyo-oka T; Handa S; Yokoyama M; Matsuzaki M; Takeshita A; Origasa H; Matsui K; Hosoda S;
Am Heart J; 2004 Feb; 147(2):324-30. PubMed ID: 14760332
[TBL] [Abstract][Full Text] [Related]
25. Carvedilol for children and adolescents with heart failure: a randomized controlled trial.
Shaddy RE; Boucek MM; Hsu DT; Boucek RJ; Canter CE; Mahony L; Ross RD; Pahl E; Blume ED; Dodd DA; Rosenthal DN; Burr J; LaSalle B; Holubkov R; Lukas MA; Tani LY;
JAMA; 2007 Sep; 298(10):1171-9. PubMed ID: 17848651
[TBL] [Abstract][Full Text] [Related]
26. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.
Packer M; Bristow MR; Cohn JN; Colucci WS; Fowler MB; Gilbert EM; Shusterman NH
N Engl J Med; 1996 May; 334(21):1349-55. PubMed ID: 8614419
[TBL] [Abstract][Full Text] [Related]
27. Beta-receptor selectivity of carvedilol and metoprolol succinate in patients with heart failure (SELECT trial): a randomized dose-ranging trial.
Zebrack JS; Munger M; Macgregor J; Lombardi WL; Stoddard GP; Gilbert EM
Pharmacotherapy; 2009 Aug; 29(8):883-90. PubMed ID: 19637941
[TBL] [Abstract][Full Text] [Related]
28. Baseline predictors of tolerability to carvedilol in patients with chronic heart failure.
Krum H; Ninio D; MacDonald P
Heart; 2000 Dec; 84(6):615-9. PubMed ID: 11083738
[TBL] [Abstract][Full Text] [Related]
29. [Prospective evaluation of effect of carvedilol therapy on heart rate variability in patients with dilated cardiomyopathy].
Hoffmann J; Grimm W; Menz V; Hufnagel G; Maisch B
Z Kardiol; 1999 Sep; 88(9):653-60. PubMed ID: 10525927
[TBL] [Abstract][Full Text] [Related]
30. [Long term use of a non-selective beta-blocker with vasodilating properties carvedilol in patients with severe heart failure].
Zaikin SY; Iosava IK; Vasechkin SS; Gruzdev AK; Sidorenko BA
Kardiologiia; 2002; 42(4):33-6. PubMed ID: 12494164
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of carvedilol for heart failure in children and patients with congenital heart disease.
Nishiyama M; Park IS; Yoshikawa T; Hatai Y; Ando M; Takahashi Y; Mori K; Murakami Y
Heart Vessels; 2009 May; 24(3):187-92. PubMed ID: 19466519
[TBL] [Abstract][Full Text] [Related]
32. Pre-discharge initiation of beta-blocker therapy in elderly patients hospitalized for acute decompensation of chronic heart failure: an effective strategy for the implementation of beta-blockade in heart failure.
Tarantini L; Cioffi G; Opasich C; Di Lenarda A; Pulignano G; Del Sindaco D; De Feo S; Stefenelli C; Russo P; Catania G
Ital Heart J; 2004 Jun; 5(6):441-9. PubMed ID: 15320569
[TBL] [Abstract][Full Text] [Related]
33. Safety and efficacy of carvedilol in very elderly diabetic patients with heart failure.
Del Sindaco D; Pulignano G; Cioffi G; Tarantini L; Di Lenarda A; De Feo S; Opasich C; Minardi G; Giovannini E; Leggio F
J Cardiovasc Med (Hagerstown); 2007 Sep; 8(9):675-82. PubMed ID: 17700396
[TBL] [Abstract][Full Text] [Related]
34. Beta-blocker therapy for heart failure outside the clinical trial setting: findings of a community-based registry.
Franciosa JA; Massie BM; Lukas MA; Nelson JJ; Lottes S; Abraham WT; Fowler M; Gilbert EM; Greenberg B;
Am Heart J; 2004 Oct; 148(4):718-26. PubMed ID: 15459606
[TBL] [Abstract][Full Text] [Related]
35. [The effect of carvedilol on apoptosis gene PDCD5 expression in chronic heart failure patients].
Wu Y; Nie XY; Hu DY; Lu PN; Zhang GQ; Luo L
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(10):676-8. PubMed ID: 15932730
[TBL] [Abstract][Full Text] [Related]
36. Rapid titration of carvedilol in patients with congestive heart failure: a randomized trial of automated telemedicine versus frequent outpatient clinic visits.
Spaeder J; Najjar SS; Gerstenblith G; Hefter G; Kern L; Palmer JG; Gottlieb SH; Kasper EK
Am Heart J; 2006 Apr; 151(4):844.e1-10. PubMed ID: 16569544
[TBL] [Abstract][Full Text] [Related]
37. Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN).
Komajda M; Lutiger B; Madeira H; Thygesen K; Bobbio M; Hildebrandt P; Jaarsma W; Riegger G; Rydén L; Scherhag A; Soler-Soler J; Remme WJ;
Eur J Heart Fail; 2004 Jun; 6(4):467-75. PubMed ID: 15182773
[TBL] [Abstract][Full Text] [Related]
38. COMPARE: comparison of the effects of carvedilol CR and carvedilol IR on left ventricular ejection fraction in patients with heart failure.
Greenberg BH; Mehra M; Teerlink JR; Ordronneau P; McCollum D; Gilbert EM
Am J Cardiol; 2006 Oct; 98(7A):53L-59L. PubMed ID: 17023233
[TBL] [Abstract][Full Text] [Related]
39. Effects of carvedilol on ventriculo-arterial coupling in patients with heart failure.
Razzolini R; Tarantini G; Boffa GM; Orlando S; Iliceto S
Ital Heart J; 2004 Jul; 5(7):517-22. PubMed ID: 15487269
[TBL] [Abstract][Full Text] [Related]
40. The benefits of early combination treatment of carvedilol and an ACE-inhibitor in mild heart failure and left ventricular systolic dysfunction. The carvedilol and ACE-inhibitor remodelling mild heart failure evaluation trial (CARMEN).
Remme WJ; Riegger G; Hildebrandt P; Komajda M; Jaarsma W; Bobbio M; Soler-Soler J; Scherhag A; Lutiger B; Rydén L
Cardiovasc Drugs Ther; 2004 Jan; 18(1):57-66. PubMed ID: 15115904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
